Farnesyl Transferase Inhibitors as a Novel Strategy for Targeting KRAS-Dependent Cancers

被引：0

作者：

Kargbo, Robert B. ^{[1
]}

机构：

[1] Usona Inst, Fitchburg, WI 53711 USA

来源：

ACS MEDICINAL CHEMISTRY LETTERS | 2025年

关键词：

D O I：

10.1021/acsmedchemlett.5c00113

中图分类号：

R914 [药物化学];

学科分类号：

100701 ;

摘要：

KRAS mutations drive tumorigenesis in multiple cancers, yet direct inhibitors display limited efficacy due to adaptive resistance. Recent preclinical findings indicate farnesyl transferase inhibitors (FTIs) can reduce compensatory mTOR and MAPK pathway activation. Evidence supports combining FTIs with KRAS inhibitors to enhance tumor suppression and delayed resistance.

引用

页数：3

共 50 条

[1] Targeting Mitochondrial Function and Biogenesis in KRAS-Dependent Pancreatic Cancer
Badejo, Adeleke Modupe
McCreary, Jordan
Szlavich, Ellyssa
True, Heather
Serrato, Ana
Love, Quintin
Malhotra, Ashim
FASEB JOURNAL, 2017, 31
[2] Synthesis of novel inhibitors of Ras farnesyl transferase
Moreno, AM
Marriott, JH
Hardcastle, IR
Rowlands, MG
Neidle, S
Jarman, M
ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 1998, 215 : U914 - U914
[3] Novel triazole based inhibitors of farnesyl transferase.
Liu, L
Saha, AK
De Corte, BL
Simoneaux, RL
Breslin, HJ
Kukla, MJ
End, DW
ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2003, 226 : U56 - U56
[4] Novel triazole based inhibitors of Ras farnesyl transferase
Saha, AK
Liu, L
Simoneaux, R
DeCorte, B
Meyer, C
Skrzat, S
Breslin, HJ
Kukla, MJ
End, DW
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2005, 15 (24) : 5407 - 5411
[5] Farnesyl transferase inhibitors: a novel targeted therapy for cancer
Johnston, Stephen R. D.
LANCET ONCOLOGY, 2001, 2 (01): : 18 - 26
[6] Farnesyl transferase inhibitors - a novel therapy for breast cancer
Johnston, SRD
Kelland, LR
ENDOCRINE-RELATED CANCER, 2001, 8 (03) : 227 - 235
[7] Design and synthesis of novel Farnesyl protein transferase inhibitors
Evans, DM
Baxter, AJ
Franklin, RJ
Jenkins, PD
Kendrick, DA
Pitt, GR
Rooker, DR
Semple, G
Ashworth, D
Elliot, L
Junien, JL
ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 1998, 215 : U914 - U914
[8] Farnesyl-transferase inhibitors show synergistic anticancer effects in combination with novel KRAS-G12C inhibitors
Marcell Baranyi
Eszter Molnár
Luca Hegedűs
Zsófia Gábriel
Flóra Gréta Petényi
Fanni Bordás
Violetta Léner
Ivan Ranđelović
Mihály Cserepes
József Tóvári
Balázs Hegedűs
József Tímár
British Journal of Cancer, 2024, 130 : 1059 - 1072
[9] TAK1 Inhibition Promotes Apoptosis in KRAS-Dependent Colon Cancers
Singh, Anurag
Sweeney, Michael F.
Yu, Min
Burger, Alexa
Greninger, Patricia
Benes, Cyril
Haber, Daniel A.
Settleman, Jeff
CELL, 2012, 148 (04) : 639 - 650
[10] Farnesyl-transferase inhibitors show synergistic anticancer effects in combination with novel KRAS-G12C inhibitors
Baranyi, Marcell
Molnar, Eszter
Hegedus, Luca
Gabriel, Zsofia
Petenyi, Flora Greta
Bordas, Fanni
Lener, Violetta
Randelovic, Ivan
Cserepes, Mihaly
Tovari, Jozsef
Hegedus, Balazs
Timar, Jozsef
BRITISH JOURNAL OF CANCER, 2024, 130 (06) : 1059 - 1072

← 1 2 3 4 5 →